These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 101411)

  • 41. [Immunochemistry of tubercle bacilli, with special reference to adjuvant activity (author's transl)].
    Azuma I
    Kekkaku; 1981 Dec; 56(12):595-607. PubMed ID: 7035731
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunotherapeutic and immunoprophylactic effects of BCG on 3-methylcholanthrene-induced autochthonous tumors in Swiss mice.
    Tokunaga T; Yamamoto S; Nakamura RM; Kataoka T
    J Natl Cancer Inst; 1974 Aug; 53(2):459-63. PubMed ID: 4602061
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of intratumor injection of live BCG on 3-methylcholanthrene-induced tumors of primary and early transplant generations in mice.
    Tanaka T
    Gan; 1974 Apr; 65(2):145-51. PubMed ID: 4600803
    [No Abstract]   [Full Text] [Related]  

  • 44. Successful regional immunotherapy with cell-wall skeletons of BCG and Nocardia rubra against autochthonous rat tumors.
    Nagano N; Yasumoto K; Tanaka K; Ichinose Y; Yaita H; Nomoto K
    Gan; 1982 Aug; 73(4):613-7. PubMed ID: 6759287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of peritoneal macrophages by oil-attached cell-wall skeleton of BCG and Nocardia rubra.
    Masuno T; Ito M; Ogura T; Hirao F; Yamawaki M; Azuma I; Yamamura Y
    Gan; 1979 Apr; 70(2):223-7. PubMed ID: 381089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of BCG on dimethylhydrazine induction of colon tumors in rats.
    Rogers AE; Gildin J
    J Natl Cancer Inst; 1975 Aug; 55(2):385-91. PubMed ID: 169375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacillus Calmette-Guérin and antilymphocyte serum in carcinogenesis. Effects on the hamster pouch.
    Giunta JL; Reif AE; Shklar G
    Arch Pathol; 1974 Oct; 98(4):237-40. PubMed ID: 4606260
    [No Abstract]   [Full Text] [Related]  

  • 48. Experimental cancer of the lung in rabbits induced by chemical carcinogens.
    Hirao F; Fujisawa T; Tsubura E; Yamamura Y
    Cancer Res; 1972 Jun; 32(6):1209-17. PubMed ID: 5030821
    [No Abstract]   [Full Text] [Related]  

  • 49. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
    Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunization of rabbits with viable BCG and nonliving cell wall vaccines.
    Larson CL; Baker RE; Baker MB
    Am Rev Respir Dis; 1968 Dec; 98(6):944-53. PubMed ID: 4881317
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies of leukemia specific antigen and immunotherapy of acute leukemia with cell-wall skeleton of BCG.
    Ohno R; Ezaki K; Morishima Y; Kodera Y; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1134-41. PubMed ID: 87101
    [No Abstract]   [Full Text] [Related]  

  • 53. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
    Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
    Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 55. Autoradiographic study on localization of fibrinogen in rabbit lung cancer.
    Ogura T; Hirao F; Tsubura E; Yamamura Y
    Gan; 1971 Oct; 62(5):367-72. PubMed ID: 5140785
    [No Abstract]   [Full Text] [Related]  

  • 56. [Anticancer immunity and cancer immunotherapy with cell wall skeleton and related synthetic compounds (author's transl)].
    Yamamura Y
    Nihon Naika Gakkai Zasshi; 1981 Aug; 70(8):1083-90. PubMed ID: 6975338
    [No Abstract]   [Full Text] [Related]  

  • 57. [Immunity against Mycobacterium, with special reference to the experiments using BCG cell wall].
    Yamamoto K
    Kekkaku; 1976 May; 51(5):155-7. PubMed ID: 819704
    [No Abstract]   [Full Text] [Related]  

  • 58. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination.
    Tanaka T; Makita H; Ohnishi M; Mori H; Satoh K; Hara A; Sumida T; Fukutani K; Tanaka T; Ogawa H
    Cancer Res; 1997 Jan; 57(2):246-52. PubMed ID: 9000563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-L-alanyl-D-isoglutamine.
    Yamamura Y; Azuma I; Sugimura K; Yamawaki M; Uemiya M
    Gan; 1976 Dec; 67(6):867-77. PubMed ID: 828599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G; Halle-Pannenko O; Bourut C
    Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.